Skip to main content
. 2022 Jul 31;37(4):e397. doi: 10.5001/omj.2022.76

Table 2. Univariate analysis of variables predicting intravenous access success among the participants (N = 511).

Variables Univariate analysis
IV success, n (%) p-value
Overall Yes No
Gender 0.924
Male 300 (58.7) 230 (76.7) 70 (23.3)
Female 211 (41.3) 161 (76.3) 50 (23.7)
Age, years* 0.866
Infant (< 1) 40 (7.9) 30 (75.0) 10 (25.0)
Toddler (1–3) 299 (59.2) 232 (77.6) 67 (22.4)
Preschool (3–5) 100 (19.8) 76 (76.0) 24 (24.0)
School (5–12) 55 (10.9) 42 (76.4) 13 (23.6)
Adolescent (12–18) 11 (2.2) 7 (63.6) 4 (36.4)
Available IV access sites
0–1 370 (72.4) 280 (75.7) 90 (24.3) -
2–3 95 (18.6) 71 (74.7) 24 (25.3) 0.212
> 3 46 (9.0) 40 (87.0) 6 (13.0) -
History of prematurity
Yes 38 (7.4) 23 (60.5) 15 (39.5) 0.052
No 215 (42.1) 166 (77.2) 49 (22.8)
Unknown 258 (50.5) 202 (78.3) 56 (21.7)
History of neonatal stay
Yes 53 (10.4) 36 (67.9) 17 (32.1) 0.119
No 458 (89.6) 355 (77.5) 103 (22.5) -
Underweight or overweight
Yes 58 (11.4) 37 (63.8) 21 (36.2) 0.015
No 453 (88.6) 354 (78.1) 99 (21.9) -
Dehydration
Yes 63 (12.3) 45 (71.4) 18 (28.6) 0.309
No 448 (87.7) 346 (77.2) 102 (22.8) -
Visibility of veins
Yes 385 (75.3) 321 (83.4) 64 (16.6) < 0.001
No 126 (24.7) 70 (55.6) 56 (44.4) -
Palpability of veins
Yes 373 (73.0) 312 (83.6) 61 (16.4) < 0.001
No 138 (27.0) 79 (57.2) 59 (42.8) -
Scars from previous IV access attempts
Yes 204 (39.9) 135 (66.2) 69 (33.8) < 0.001
No 307 (60.1) 256 (83.4) 51 (16.6) -
Child cooperation
Yes 243 (47.6) 199 (81.9) 44 (18.1) 0.006
No 268 (52.4) 192 (71.6) 76 (28.4) -
Parent cooperation†
Yes 250 (50.2) 201 (80.4) 49 (19.6) 0.024
No 248 (49.8) 178 (71.8) 70 (28.2) -
IV access experience, years‡
≤ 5 86 (17.0) 69 (80.2) 17 (19.8) -
5.1–10 171 (33.8) 126 (73.7) 45 (26.3) 0.668
10.1–15 129 (25.5) 100 (77.5) 29 (22.5) -
≥ 15.1 120 (23.7) 93 (77.5) 27 (22.5) -
Overall nursing experience, years‡
≤ 5 88 (17.4) 69 (78.4) 19 (21.6) -
5.1–10 173 (34.2) 129 (74.6) 44 (25.4) 0.857
10.1–15 129 (25.5) 101 (78.3) 28 (21.7) -
≥ 15.1 116 (22.9) 89 (76.7) 27 (23.3) -

IV: intravenous. *Percentages for this variable are calculated out of 505 due to missing data. †Percentages for this variable are calculated out of 498 due to missing data. ‡Percentages for these variables are calculated out of 506 due to missing data.